SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 607 filers reported holding SEAGEN INC in Q3 2023. The put-call ratio across all filers is 3.99 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,714,556 | -0.3% | 78,786 | -9.5% | 0.01% | 0.0% |
| Q2 2023 | $16,757,069 | -28.4% | 87,068 | -24.7% | 0.01% | -28.6% |
| Q1 2023 | $23,395,975 | +34.8% | 115,552 | -14.4% | 0.01% | +40.0% |
| Q4 2022 | $17,350,694 | -29.7% | 135,014 | -25.2% | 0.01% | -37.5% |
| Q3 2022 | $24,698,000 | -14.1% | 180,504 | +11.0% | 0.01% | 0.0% |
| Q2 2022 | $28,762,000 | +53.0% | 162,553 | +24.5% | 0.01% | +60.0% |
| Q1 2022 | $18,803,000 | +2.7% | 130,528 | +10.3% | 0.01% | 0.0% |
| Q4 2021 | $18,302,000 | -61.9% | 118,385 | -58.2% | 0.01% | -54.5% |
| Q3 2021 | $48,063,000 | +45.0% | 283,057 | +34.9% | 0.01% | +57.1% |
| Q2 2021 | $33,136,000 | -37.2% | 209,881 | -44.8% | 0.01% | -41.7% |
| Q1 2021 | $52,770,000 | -23.2% | 380,028 | -3.1% | 0.01% | -29.4% |
| Q4 2020 | $68,705,000 | – | 392,286 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |